Environmental Microbiology,
Journal Year:
2022,
Volume and Issue:
25(1), P. 115 - 125
Published: Oct. 9, 2022
In
the
medical,
environmental,
and
biotechnological
fields,
microbial
communities
have
attracted
much
attention
due
to
their
roles
numerous
possible
applications.
The
study
of
these
is
challenging
diversity
complexity.
Innovative
methods
are
needed
identify
taxonomic
components
individual
microbiota,
changes
over
time,
determine
how
microoorganisms
interact
function.
Metaproteomics
based
on
identification
quantification
proteins,
can
potentially
provide
this
full
picture.
Due
wide
molecular
panorama
functional
insights
it
provides,
metaproteomics
gaining
momentum
in
microbiome
holobiont
research.
Its
potential
should
be
unleashed
coming
years
with
progress
speed
cost
analyses.
exploratory
crystal
ball
exercise,
I
discuss
technical
conceptual
advances
that
expect
drive
innovative
research
next
few
microbiology.
also
debate
concepts
'microbial
dark
matter'
'Metaproteomics-Assembled
Proteomes
(MAPs)'
present
some
long-term
prospects
for
clinical
diagnostics
personalized
medicine,
environmental
monitoring,
agriculture,
biotechnology.
Journal of Proteome Research,
Journal Year:
2023,
Volume and Issue:
22(7), P. 2151 - 2171
Published: June 1, 2023
Mass
spectrometry
is
unmatched
in
its
versatility
for
studying
practically
any
aspect
of
the
proteome.
Because
foundations
mass
spectrometry-based
proteomics
are
complex
and
span
multiple
scientific
fields,
can
be
perceived
as
having
a
high
barrier
to
entry.
This
tutorial
intended
an
accessible
illustrated
guide
technical
details
relatively
simple
quantitative
proteomic
experiment.
An
attempt
made
explain
relevant
concepts
those
with
limited
knowledge
basic
understanding
proteins.
experimental
overview
provided,
from
beginning
sample
preparation
analysis
protein
group
quantities,
explanations
how
data
acquired,
processed,
analyzed.
A
selection
advanced
topics
briefly
surveyed
works
further
reading
cited.
To
conclude,
brief
discussion
future
given,
considering
next-generation
sequencing
technologies
that
may
complement
create
fruitful
proteomics.
Genome biology,
Journal Year:
2022,
Volume and Issue:
23(1)
Published: Dec. 16, 2022
Many
biological
processes,
such
as
cell
division
cycle
and
drug
resistance,
are
reflected
in
protein
covariation
across
single
cells.
This
can
be
quantified
interpreted
by
single-cell
mass
spectrometry
with
sufficiently
high
throughput
accuracy.
Nature Methods,
Journal Year:
2023,
Volume and Issue:
20(10), P. 1530 - 1536
Published: Oct. 1, 2023
Single-cell
proteomics
by
mass
spectrometry
is
emerging
as
a
powerful
and
unbiased
method
for
the
characterization
of
biological
heterogeneity.
So
far,
it
has
been
limited
to
cultured
cells,
whereas
an
expansion
complex
tissues
would
greatly
enhance
insights.
Here
we
describe
single-cell
Deep
Visual
Proteomics
(scDVP),
technology
that
integrates
high-content
imaging,
laser
microdissection
multiplexed
spectrometry.
scDVP
resolves
context-dependent,
spatial
proteome
murine
hepatocytes
at
current
depth
1,700
proteins
from
cell
slice.
Half
was
differentially
regulated
in
manner,
with
protein
levels
changing
dramatically
proximity
central
vein.
We
applied
machine
learning
classes
images,
which
subsequently
inferred
imaging
data
alone.
applicable
healthy
diseased
complements
other
omics
technologies.
Molecular & Cellular Proteomics,
Journal Year:
2023,
Volume and Issue:
22(7), P. 100577 - 100577
Published: May 19, 2023
Accurate
biomarkers
are
a
crucial
and
necessary
precondition
for
precision
medicine,
yet
existing
ones
often
unspecific
new
have
been
very
slow
to
enter
the
clinic.
Mass
spectrometry
(MS)-based
proteomics
excels
by
its
untargeted
nature,
specificity
of
identification,
quantification,
making
it
an
ideal
technology
biomarker
discovery
routine
measurement.
It
has
unique
attributes
compared
affinity
binder
technologies,
such
as
OLINK
Proximity
Extension
Assay
SOMAscan.
In
in
previous
review
2017,
we
described
technological
conceptual
limitations
that
had
held
back
success.
We
proposed
'rectangular
strategy'
better
separate
true
minimizing
cohort-specific
effects.
Today,
this
converged
with
advances
MS-based
technology,
increased
sample
throughput,
depth
quantification.
As
result,
studies
become
more
successful,
producing
candidates
withstand
independent
verification
and,
some
cases,
already
outperform
state-of-the-art
clinical
assays.
summarize
developments
over
last
years,
including
benefits
large
cohorts,
which
acceptance.
Shorter
gradients,
scan
modes,
multiplexing
about
drastically
increase
cross-study
integration,
proxies
absolute
levels.
found
multiprotein
panels
inherently
robust
than
current
single
analyte
tests
capture
complexity
human
phenotypes.
Routine
MS
measurement
clinic
is
fast
becoming
viable
option.
The
full
set
proteins
body
fluid
(global
proteome)
most
important
reference
best
process
control.
Additionally,
increasingly
all
information
could
be
obtained
from
targeted
analysis
although
latter
may
straightforward
way
regular
use.
Many
challenges
remain,
not
least
regulatory
ethical
but
outlook
applications
never
brighter.
PROTEOMICS,
Journal Year:
2022,
Volume and Issue:
23(7-8)
Published: Nov. 9, 2022
Abstract
There
are
multiple
reasons
why
the
next
generation
of
biological
and
medical
studies
require
increasing
numbers
samples.
Biological
systems
dynamic,
effect
a
perturbation
depends
on
genetic
background
environment.
As
consequence,
many
conditions
need
to
be
considered
reach
generalizable
conclusions.
Moreover,
human
population
clinical
only
sufficient
statistical
power
if
conducted
at
scale
with
precise
measurement
methods.
Finally,
proteins
remain
without
functional
annotations,
because
they
have
not
been
systematically
studied
under
broad
range
conditions.
In
this
review,
we
discuss
latest
technical
developments
in
mass
spectrometry
(MS)‐based
proteomics
that
facilitate
large‐scale
by
fast
efficient
chromatography,
scanning
spectrometers,
data‐independent
acquisition
(DIA),
new
software.
We
further
highlight
recent
which
demonstrate
how
high‐throughput
(HT)
can
applied
capture
diversity,
annotate
gene
functions
or
generate
predictive
prognostic
models
for
diseases.
Nature Methods,
Journal Year:
2023,
Volume and Issue:
20(5), P. 714 - 722
Published: April 3, 2023
Major
aims
of
single-cell
proteomics
include
increasing
the
consistency,
sensitivity
and
depth
protein
quantification,
especially
for
proteins
modifications
biological
interest.
Here,
to
simultaneously
advance
all
these
aims,
we
developed
prioritized
Single-Cell
ProtEomics
(pSCoPE).
pSCoPE
consistently
analyzes
thousands
peptides
across
single
cells
(thus
data
completeness)
while
maximizing
instrument
time
spent
analyzing
identifiable
peptides,
thus
proteome
depth.
These
strategies
increased
sensitivity,
completeness
coverage
over
twofold.
The
gains
enabled
quantifying
variation
in
untreated
lipopolysaccharide-treated
primary
macrophages.
Within
each
condition,
covaried
within
functional
sets,
including
phagosome
maturation
proton
transport,
similarly
both
treatment
conditions.
This
covariation
is
coupled
phenotypic
variability
endocytic
activity.
also
proteolytic
products,
suggesting
a
gradient
cathepsin
activities
condition.
freely
available
widely
applicable,
interest
without
sacrificing
coverage.
Support
at
http://scp.slavovlab.net/pSCoPE
.
Molecular Systems Biology,
Journal Year:
2023,
Volume and Issue:
19(9)
Published: Aug. 21, 2023
Single-cell
proteomics
aims
to
characterize
biological
function
and
heterogeneity
at
the
level
of
proteins
in
an
unbiased
manner.
It
is
currently
limited
proteomic
depth,
throughput,
robustness,
which
we
address
here
by
a
streamlined
multiplexed
workflow
using
data-independent
acquisition
(mDIA).
We
demonstrate
automated
complete
dimethyl
labeling
bulk
or
single-cell
samples,
without
losing
depth.
Lys-N
digestion
enables
five-plex
quantification
MS1
MS2
level.
Because
channels
are
quantitatively
isolated
from
each
other,
mDIA
accommodates
reference
channel
that
does
not
interfere
with
target
channels.
Our
algorithm
RefQuant
takes
advantage
this
confidently
quantifies
twice
as
many
per
single
cell
compared
our
previous
work
(Brunner
et
al,
PMID
35226415),
while
allows
routine
analysis
80
cells
day.
Finally,
combined
spatial
increase
throughput
Deep
Visual
Proteomics
seven-fold
for
microdissection
four-fold
MS
analysis.
Applying
primary
cutaneous
melanoma,
discovered
signatures
within
distinct
tumor
microenvironments,
showcasing
its
potential
precision
oncology.